-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster III

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Selim Corbacioglu, MD1, Ansgar S. Schulz, MD2*, Petr Sedlacek, MD, PhD3*, Bernd Gruhn, MD4*, Simone Cesaro, MD5*, Peter Bader, MD6 and on Behalf Of The Pediatric Disease Working Party7*

1University of Regensburg, Regensburg, Germany
2Department of Pediatrics, University Medical Center, Ulm, Germany
3University Hospital Motol, Prague, Czech Republic
4University Hospital of Jena, Jena, Germany
5University of Padova, Padova, Italy
6University Children's Hospital, Frankfurt, Germany
7Gentium S.p.A., Villa Guardia, Italy

Paul G. Richardson, MD1, Angela R. Smith, MD, MS2, Brandon M. Triplett, MD3*, Nancy A. Kernan, MD4, Stephan A. Grupp, MD, PhD5, Joseph H. Antin, MD6, Leslie E. Lehmann, MD7, Maja Miloslavsky, PhD8*, Robin L. Hume, MS8*, Alison L. Hannah, MD8, Bijan Nejadnik, MD8 and Robert J. Soiffer, MD9

1Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
3Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
4Pediatric BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
6Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
7Center for Stem Cell Transplantation, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8Jazz Pharmaceuticals, Palo Alto, CA
9Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Michelle K Yong1,2*, Monica Slavin3,4*, David S. Ritchie, MD, PhD3,5, Andrew Spencer6, Paul U Cameron1,2*, Orla Morrissey1*, Allen Cheng1*, Assia Samri7*, Guislaine Carcelain7*, Brigitte Autran7* and Sharon R Lewin1,2*

1Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, Australia
2The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia
3Peter MacCallum Cancer Centre, Melbourne, Australia
4Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
5Royal Melbourne Hospital, Parkville, Australia
6Department of Haematology, Monash University and Alfred Hospital, Melbourne, Australia
7Department of Immunology, University Pierre and Marie Curie and Hôpital Pitié Salpêtrière, Paris, France

Moniek de Witte, MD PhD1*, Gerjan Fleurke2*, Laura Timmerman1*, Ineke Slaper, PhD3*, Eric Spierings, PhD1* and Jurgen Kuball, MD PhD1,2

1Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands
2Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
3Cell Therapy Facility, University Medical Center Utrecht, Utrecht, Netherlands

Judith Trotman, MBChB1,2, Peter J. Shaw, MBBS, MA, FRACP3,4, Campbell Tiley, MBBS, FRACP, FRCPA5, Sundra Ramanathan, MBBS FRCPA FRACP6*, Andrew P Grigg, MBBS MD7,8, Stephen Robert Larsen, MBBS PhD FRCPA FRACP9, Peter Presgrave, MBBS, PhD, FRACP, FRCPA10,11, Yiu-Lam Kwan, MBBS, FRACP, FRCPA12*, Elizabeth Newman, RN13* and Christa Nath, BSC (Hons), PhD14*

1Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
2University of Sydney, Concord, Australia
3University of Sydney, Sydney, Australia
4Dept. of Oncology, The Children's Hosp. at Westmead, Sydney, Australia
5Central Coast Health, Gosford, Australia
6St George Hospital, Kogarah, Australia
7Austin Health, Melbourne, Australia
8University of Melbourne, Melbourne, Australia
9Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, Australia
10Dept. of Hematology, Wollongong Hosp., Wollongong, Australia
11University of Wollongong, Wollongong, Australia
12Haematology, Concord Repatriation General Hospital, New South Wales 2139, Australia
13Concord Repatriation General Hospital, Concord, Australia
14Children's Hospital at Westmead, Westmead, Australia

M Joseph John, MD, DM*, Amrith Mathew, MD* and Chepsy C Philip, DM*

Department of Clinical Haematology, Haemato-Oncology & Bone Marrow (Stem cell) Transplantation, Christian Medical College, Ludhiana, India

Sandra Eder, MD1,2*, Eric Beohou1*, Myriam Labopin, MD3*, Jaime Sanz, MD4*, Jürgen Finke, M.D.5, William Arcese, MD6, Reuven Or7*, Francesca Bonifazi8*, Agostino Cortelezzi, MD9, Ignazio Majolino, MD10, Andrea Bacigalupo, MD11, Alexandros Spyridonidis12, Emilio Paolo Alessandrino, MD13*, Sebastian Giebel, MD, PhD1,14*, Mohamad Mohty, MD, PhD1,2 and Arnon Nagler, MD, MSc3,15

1Hôpital Saint-Antoine, EBMT, Acute Leukemia Working Party and Registry, Paris, France
2Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
3EBMT, Acute Leukemia Working Party, Paris, France
4Servicio de Hematología, Hospital Universitari i politècnic La Fe, Valencia, Spain
5University Medical Center Freiburg, Freiburg, Germany
6Dept. of Hematology and Transplant, University of Rome 'Tor Vergata', Rome, Italy
7Hadassah University Hospital, Jerusalem, Israel
8S.Orsola-Malpighi Hospital Institute of Hematology & Medical, Oncology L & A Seràgnoli, Bologna University, Bologna, Italy
9Oncohematology Unit, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
10Ematologia, Ospedale S. Camillo, Rome, Italy
11Second Division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
12Haematology Division, Patras University Medical School, University Hospital, Patras, Greece
13Hematology, Policlinico San Matteo e Università di Pavia, Pavia, Italy
14Dept. of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
15Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

Josu de la Fuente, PhD, FRCP, FRCPI, FRCPCH, FRCPath1,2, Farah O'Boyle, PhD1*, Yvonne Harrington1*, Anne Bradshaw3*, Sandra Hing, PhD4*, Subarna Chakravorty, PhD, FRCPath1*, Leena Karnik, MD, FRCPath, MBBS,5*, Helen New, PhD FRCPath1*, Richard Szydlo, PhD2*, Baba PD Inusa, MBBS, FMCPaed, FRCPCH, MRCP, DCP6 and Paul Telfer, FRCPath, MD7*

1Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
2Centre for Haematology, Imperial College London, London, United Kingdom
3Centre for Haematology, Hammersmith Hospital, Imperial College NHS Healthcare Trust, London, United Kingdom
4Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
5Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
6Paediatrics and Haemoglobinopathies, Evelina Children's Hospital, St Thomas' Hospital NHS Trust, London, United Kingdom
7The Royal London Hospital, London, United Kingdom

Dusan Prevalsek, MD1*, Susanne Fritsch, MD1*, Max Hubmann, MD1*, Nicole Engel, MD1*, Anna-Katharina Zoellner, MD1*, Thomas Köhnke, MD2*, Veit Leonhard Bücklein, MD2*, Christoph Schulz, MD1*, Friederike Mumm, MD1*, Christina Theresa Rieger, MD1*, Georg Ledderose, MD1*, Hans-Joachim Stemmler, MD1*, Karsten Spiekermann, MD3, Wolfgang Hiddemann, MD1, Andreas Hausmann, MD1,4* and Johanna Tischer, MD1*

1Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany
2Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany
3Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
4Klinikum München-Schwabing, Department I of Internal Medicine, Munich, Germany

Bertrand Routy, MD1, Caroline Letendre, MD2, Maxime Chenard-Poirier, MD3*, Vikram Mehraj, PhD4*, David Enot1*, Khaled Guenda, MD5*, Noemie Charbonneau Séguin6*, Kathia Gagnon7* and Silvy Lachance, MD8

1Gustave Roussy Comprehensive Cancer Center, Villejuif, France
2Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
34. Department of Medicine, Division of Hematology and Oncology, Centre hospitalier universitaire de Quebec, Quebec, QC, Canada
4Research Institute, McGill University Health Centre, Montreal, QC, Canada
5Department of Medicine, Division of Hematology and Oncology, Heamatopoietic Cell Transplant Program, Montreal, QC, Canada
6Department of Medicine, Division of Hematology and Oncology, Heamatopoietic Cell Transplant Program, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada
7Department of Medicine, Division of Hematology and Oncology, Heamatopoietic Cell Transplant Program, Hôpital Maisonneuve-Rosemont Research Cente, Montreal, QC, Canada
8Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, QC, Canada

Yao-Ting Hayden Huang, PhD, MPH1, Seong Jin Kim, MPH1*, Yeon Joo Lee, MD, MPH1,2*, Daniel Burack, BS1*, Paige Nichols, BA1*, Molly Maloy, MS3*, Roni Tamari, MD2,3, Miguel-Angel Perales, MD2,4, Sergio A. Giralt, MD2,4, Hugo R. Castro-Malaspina, MD2,3, Esperanza B Papadopoulos, MD2,3, Ann A. Jakubowski, MD, PhD2,3* and Genovefa A Papanicolaou, MD1,2*

1Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Weill Cornell Medical College, Cornell University, New York, NY
3Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Adult Bone Marrow Transplantation Services, Memorial Sloan Kettering Cancer Center, New York, NY

Gabriela Rondon, MD, Rima M Saliba, Ph.D*, Julianne Chen*, Celina Ledesma*, Amin M. Alousi, MD, Betul Oran, MD, Chitra M. Hosing, MD, Partow Kebriaei, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Uday R. Popat, MD, Richard E. Champlin, MD and Stefan O. Ciurea, MD

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Ezhil Pavai Mohanan, MSc1*, Shareen Stella Backia Royan, BSc2*, John C Panetta, PhD3*, Fouzia Nambiathayil Abubacker, DM2*, Anu Korula, MD, DM1*, Aby Abraham, MD, DM1*, Auro Viswabandya, MD, DM1,4, Biju George, DM1, Alok Srivastava, MD, FRACP1,5, Vikram Mathews, DM1 and Poonkuzhali Balasubramanian, Ph.D1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Hematology, Christian Medical College, Vellore, India
3Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN
4Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
5Christian Medical College, Centre for Stem Cell Research, Vellore, India

Tiago Nava, MD1*, Marc Ansari, MD2,3,4, Yves Theoret, PhD5,6,7*, Mohamed Aziz Rezgui5,6*, Samira Mezziani1*, Marie-France Vachon1*, Michel Duval, MD1,5,8, Maja Krajinovic, PhD5,6,7* and Henrique Bittencourt, MD, PhD1,5,8

1Onco-Hematology Division, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
2Onco-Hematology Unit, Department of Pediatrics, University of Geneva, Geneva, Switzerland
3Department of Pediatrics, CANSEARCH Research Laboratory, Faculty of Medicine, Geneva, Switzerland
4Department of Pediatrics, Onco-hematology Unit, Geneva University Hospitals, Geneva, Switzerland
5Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Montreal, QC, Canada
6Department of Pharmacology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada
7Clinical Pharmacology Unit, CHU Sainte-Justine Research Center, Montreal, QC, Canada
8Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Canada

Mauricette Michallet, MD, PhD, Mohamad Sobh, PharmD*, Hélène Labussière-wallet, MD*, Marie Balsat, MD*, Caroline Lejeune, MD*, Sophie Ducastelle-Leprêtre, MD*, Fiorenza Barraco, MD*, Xavier Thomas and Franck E. Nicolini, MD, PhD

Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France

Maximilian Mossner1*, Birgit Spiess, PhD2*, Johann-Christoph Jann1*, Verena Nowak1*, Julia Obländer2*, Oliver Bader3*, Wolf-Karsten Hofmann, MD1, Daniel Nowak, MD1*, Dieter Buchheidt, MD2* and Tobias Boch, MD1*

1Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
2Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
3Institute for Medical Microbiology, University Medical Center Göttingen, Göttingen, Germany

Alexandre Amin, PharmD1*, Philippe Bourget, PharmD, PhD1*, Benedicte Neven, MD, PhD2*, Marie-Louise Fremond, MD2*, Martin Castelle, MD2*, Elodie Elkaim, MD2*, Guilhem Cros, MD2*, Despina Moshous, MD2*, Fabien Touzot, MD2*, Alexandre Lalli, PharmD1*, Aurélie Petain3*, Laurent Nguyen3* and Stephane Blanche2*

1Clinical Pharmacy Department, University Hospital Necker-Enfants Malades, Paris, France
2Pediatric Hematology-Immunology and Rhumatology Department, University Hospital Necker-Enfants Malades, Paris, France
3Pharmacokinetic Department, Institut de Recherche Pierre Fabre, Toulouse, France

Asad Bashey, MD, PhD1, Xu Zhang, PhD2*, Katelin Jackson1*, Stacey Brown, B.A.1*, Melhem Solh, MD1, Lawrence E. Morris, MD1, H. Kent Holland, MD1 and Scott R. Solomon, MD1

1The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
2Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Hassan Issa, MD1*, Amy S. Ruppert, MAS2*, Patrick Elder, M.S3*, Craig Hofmeister4, Don M Benson, MD, PhD5, Sam Penza, MD6*, Leslie A. Andritsos, MD2, Rebecca B. Klisovic, MD7, Sumithira Vasu, MBBS8, William Blum, M.D.9, Samantha M. Jaglowski, MD3*, Steven M. Devine, MD3 and Yvonne A Efebera, MD10

1Department of Medicine, Washington University School of Medicine, St Louis, MO
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Ohio State University, Columbus, OH
4Division of Hematology, Ohio State University Medical Center, Columbus, OH
5Division of Hematology, Ohio State University, Columbus, OH
6Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
7Division of Hematology, The Ohio State University, columbus, OH
8Comprehensive Cancer Center, The Ohio State University, Columbus, OH
9Division of Hematology-Oncology, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH
10The Ohio State University, Columbus, OH

Mark Vander Lugt, MD1*, Hey Jin Chong, MD, PhD2*, Xiaohua Chen, MD PhD1*, Randy M. Windreich, MD1, Rakesh Goyal, MD, MRCP1, Maria Escolar, MD3* and Paul Szabolcs, MD4

1Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
2Department of Pediatrics, Division of Allergy/Immunology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
3Department of Pediatrics, The Neurodevelopment in Rare Diseases Program, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
4Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh, Pittsburgh, PA

Nancy A. Kernan, MD1, Stephan A. Grupp, MD, PhD2, Kamalika Banerjee, MS3*, Alison L. Hannah, MD3, Robin L. Hume, MS3*, Bijan Nejadnik, MD3 and Paul Richardson, MD4

1Pediatric BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
3Jazz Pharmaceuticals, Palo Alto, CA
4Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Hamilton C. Tsang, MD1*, Lohith S. Bachegowda, MD2*, Ruchika Goel, MD, MPH1*, Nebu V. Koshy, MD3*, Usama Gergis, MD4*, Yen-Michael S. Hsu, MD, PhD1, Sebastian A. Mayer, MD4*, Tsiporah B. Shore, MD4, Koen van Besien, MD4, Melissa M. Cushing, MD1 and Ljiljana V. Vasovic, MD1*

1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/ New York Presbyterian Hospital, New York, NY
2New York Blood Center, New York, NY
3Department of Medicine, Weill Cornell Medical College/ New York Presbyterian Hospital, New York, NY
4Division of Hematology and Medical Oncology, Weill Cornell Medical College/ New York Presbyterian Hospital, New York, NY

Valkal Bhatt, PharmD1*, Meighan Palazzo, NP1*, Kathleen Kilroy, NP1*, Patrick Hilden, MS2*, Molly Maloy, MS1*, Juliet N. Barker, MBBS (Hons)1, Hugo R. Castro-Malaspina, MD1, David J Chung, MD PhD1, Parastoo B Dahi, MD1, Katharine C. Hsu, MD, PhD1*, Alan M Hanash, MD, PhD1, Ann A. Jakubowski, MD, PhD1*, Robert R. Jenq, MD1*, Guenther Koehne, MD, PhD1, Heather Landau, MD1, Esperanza B Papadopoulos, MD1, Miguel-Angel Perales, MD1, Craig S. Sauter, MD1, Roni Tamari, MD1, Marcel van den Brink, MD, PhD1, James W. Young, MD1, Sergio A. Giralt, MD1 and Doris M Ponce, MD1

1Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY

Amy Rose Cantilena, BS1*, Tara L. Lin, MD2, Siddhartha Ganguly, MD3, Leyla Shune, MD3*, Anurag K. Singh, MD3, Sunil Abhyankar, MD3, Jonathan Mahnken, PhD4*, Dennis Allin5*, Joseph McGuirk, DO3 and Omar S. Aljitawi, MD2

1Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS
2Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City, KS
3Division of Hematology/Oncology and Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS
4Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS
5Department of Emergency Medicine, University of Kansas Medical Center, Kansas City, KS

Henrique Bittencourt, MD1,2, Marie-France Vachon3*, Isabelle Louis4*, Ernestine Chablis5*, Marion Cortier5*, Edith Villeneuve6*, Pierre Teira, MD, MS7, Sonia Cellot, MD PhD8*, Elie Haddad, MD9* and Michel Duval, MD1,3

1Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Canada
2Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Hematology-Oncology Division, Montreal, QC, Canada
3Onco-Hematology Division, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
4Cellular Therapy Laboratory, CHU Sainte-Justine, Montreal, QC, Canada
5CHU Sainte-Justine, Montreal, QC, Canada
6Anestesiology Department, CHU Sainte-Justine, Montreal, QC, Canada
7Hematology-Oncology Division, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
8Hematology-Oncology Division, Charles Bruneau Cancer Center, CHU Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada
9Immunology Division, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada

Raffaella Greco, MD1*, Maria Chiara Barbanti, MD2*, Alessandra Forcina, MD2*, Maria Teresa Lupo Stanghellini, MD2*, Fabio Giglio, MD2*, Mara Morelli, MD2*, Luca Vago, MD, PhD1,3, Simona Piemontese, MD2*, Carlo Messina, MD2*, Elisa Sala, MD2*, Francesca Pavesi, MD2*, Sarah Marktel, MD2*, Matteo G Carrabba, MD1*, Andrea Assanelli, MD4*, Massimo Bernardi, MD2*, Jacopo Peccatori, MD2*, Consuelo Corti, MD2* and Fabio Ciceri, MD4,5*

1Unit of Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milano, Italy
2Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
3Unit of Immunogenetics, Leukemia Genomics and Immunobiology, San Raffaele Scientific Institute, Milano, Italy
4Hematology and Bone Marrow Transplantation Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
5Vita-Salute San Raffaele University, Milan, Italy

Stefania Bregante1*, Alida Dominietto, MD2*, Anna Ghiso1*, Anna Maria Raiola1*, Francesca Gualandi, MD3*, Riccardo Varaldo1*, Carmen Di Grazia, MD4*, Teresa Lamparelli1*, Silvia Luchetti1*, Simona Geroldi1*, Lucia Casarino1*, Sarah Pozzi1*, Elisabetta Tedone1*, Maria Teresa van Lint, MD5*, Federica Galaverna1*, Gianni Barosi6* and Andrea Bacigalupo, MD5

1Divisione Ematologia e Trapianto di Midollo, IRCCS San Martino-IST, Genoa, Italy
2Second division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
3Second division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
4Second Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
5Second Division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
6Unità di Epidemiologia Clinica, Centro per lo studio della Mielofibrosi, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

Yuan Kong, MD, PhD1*, Yue Hu1,2*, Yang Song1,2*, Yu-Tong Wang1*, Zheng-Fan Jiang2,3*, Hong-Kui Deng2,3* and Xiao Jun Huang1,2

1Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of HSCT, Beijing, China
2Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
3Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, School of Life Sciences, Peking University, Beijing, China

Michaela Döring, MD1*, Karin Melanie Cabanillas Stanchi1*, Manon Queudeville, MD1*, Judith Feucht, MD1*, Patrick Schlegel, MD1*, Tobias Feuchtinger, MD2, Peter Lang, MD1, Rupert Handgretinger, Prof. MD1 and Werner J. Heinz, MD3*

1Department of General Paediatrics, Oncology/Haematology, University Children's Hospital, Tuebingen, Germany
2Dr. von Hauner'sches Kinderspital - Hematology/Oncology, University of Munich, Munich, Germany
3Medizinische Klinik and Poliklinik II, University Hospital, Würzburg, Germany

Alice Garnier, MD1*, Thierry Guillaume, MD1*, Pierre Peterlin, MD1*, Beatrice Mahe, MD1*, Viviane Dubruille, MD1*, Nicolas Blin, MD1*, Maud Voldoire, MD1*, Thomas Gastinne, MD2*, Cyrille Touzeau, MD, PHD1*, Steven Le Gouill, MD, PhD1*, Yannick Le Bris, PharmD3*, Marion Eveillard, PharmD3*, Marie C Bene, PharmSciD, PhD3*, Marina Illiaquer, PharmD4*, Berthe marie Imbert5*, Philippe Moreau, MD, PhD6* and Patrice Chevallier, MD, PhD1*

1Department of Hematology, Nantes University Hospital, Nantes, France
2Hematology Department, CHU Nantes, Nantes, France
3Hematology Laboratory, Nantes University Hospital, Nantes, France
4Virology Laboratory, Nantes University Hospital, Nantes, France
5Virology Laboratory, Nantes University Hospital, nantes, France
6Nantes University Hospital, Hôtel Dieu, Nantes, France

*signifies non-member of ASH